- Home
- applications
- stroke patient
Show results for
Refine by
Stroke Patient Product Applications
5 applications found
Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients. NICE guidance (MTG19) supports the geko™ device to reduce thromboembolism risk for patients when other mechanical and pharmacological methods of prophylaxis are impractical or ...
ByFirstkind Ltd based in High Wycombe, UNITED KINGDOM
This website is designed to assist patients, family members, and caregivers in obtaining valuable information about the EMAGINE study, and to support the process of eligibility evaluation, and research study enrollment for potential participants. The BQ 2.0 system (designed and manufactured by BrainQ Technologies Ltd.) is an investigational device, meaning it has not been approved by the FDA, the use of which has had no related adverse events to date. ...
ByBrainQ Technologies based in Jerusalem, ISRAEL
Current practice acknowledges that a reduction in venous stasis of the lower limb reduces DVT incidence in acute stroke patients1. It is also recognised that DVT is a blood clot that most commonly forms in the deep veins of the ...
ByFirstkind Ltd based in High Wycombe, UNITED KINGDOM
Stroke upper limb rehabilitation with Axinesis: If you have a neurological condition, rehabilitation should help you achieve optimal outcomes while being safe and engaging. Axinesis’s neurorehabilitation devices support effective upper extremity rehabilitation in conditions such as stroke, Parkinson’s disease, cerebral palsy and multiple ...
ByAxinesis based in Wavre, BELGIUM
Stroke represents one of the largest medical challenges facing our society today. In the U.S., someone has a stroke every 40 seconds and every four minutes someone will die as a result of stroke. Stroke is the 5th leading cause of death in the U.S. and the 2nd leading cause of death worldwide. In the U.S. stroke kills approximately 130,000 people each year (roughly 1 in every 20 deaths). Nearly 800,000 people have a stroke in the U.S. each year and approximately 87% are classified as ischemic (the result of a ...
ByCerevast Medical, Inc. based in Bothell, WASHINGTON (USA)